【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Refractory Multiple Myeloma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Refractory Multiple Myeloma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Refractory Multiple Myeloma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Refractory Multiple Myeloma 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Refractory Multiple Myeloma Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Refractory Multiple Myeloma 36
Mar 05, 2014: Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma 36
Jan 22, 2014: Global Phase 3 Trial Commenced in Asia for Ixazomib, Takeda’s Oral Proteasome Inhibitor 36
Dec 12, 2013: Clinical Study with Indatuximab Ravtansine (BT-062) in Multiple Myeloma shows good Tolerability and encouraging Efficacy in Combination with Lenalidomide and Dexamethasone 37
Nov 19, 2013: Oral Proteasome Inhibitor MLN9708 Enters into Phase 3 Clinical Study in Japan 38
Sep 10, 2013: Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma 38
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
Celgene Corporation 40
Clinical Trial Overview of Celgene Corporation 40
Amgen Inc. 44
Clinical Trial Overview of Amgen Inc. 44
Johnson & Johnson 46
Clinical Trial Overview of Johnson & Johnson 46
Takeda Pharmaceutical Company Limited 48
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 48
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Merck & Co., Inc. 52
Clinical Trial Overview of Merck & Co., Inc. 52
F. Hoffmann-La Roche Ltd. 53
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 53
Pfizer Inc. 54
Clinical Trial Overview of Pfizer Inc. 54
Bristol-Myers Squibb Company 55
Clinical Trial Overview of Bristol-Myers Squibb Company 55
AbbVie Inc. 56
Clinical Trial Overview of AbbVie Inc. 56
Clinical Trial Overview of Top Institutes / Government 57
National Cancer Institute 57
Clinical Trial Overview of National Cancer Institute 57
Fred Hutchinson Cancer Research Center 60
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 60
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
University of Arkansas 66
Clinical Trial Overview of University of Arkansas 66
Case Comprehensive Cancer Center 67
Clinical Trial Overview of Case Comprehensive Cancer Center 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
City of Hope National Medical Center 69
Clinical Trial Overview of City of Hope National Medical Center 69
Washington University School of Medicine 70
Clinical Trial Overview of Washington University School of Medicine 70
Five Key Clinical Profiles 71
Appendix 163
Abbreviations 163
Definitions 163
Research Methodology 164
Secondary Research 164
About GlobalData 165
Contact Us 165
Disclaimer 165
Source 166
【レポート販売概要】
■ タイトル：不応性多発性骨髄腫：グローバル臨床試験レビュー（2014年上半期）■ 英文：Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月15日
■ 調査会社：GlobalData
■ 商品コード：GDHC2084CTIDB
■ 調査対象地域：グローバル
- 世界のスケール防止剤市場：ホスホン酸系、カルボン酸/アクリル系、スルホン酸系スケール防止剤Scale inhibitor (antiscalants) are chemical substances that, when added to industrial water at very low levels, act to reduce or prevent the formation of scale. They can be classified into phosphonates, carboxylate/acrylic, sulfonates, and others. Scale inhibitor are widely preferred nowadays across different industries that include power & construction, mining, oil & gas, water & waste water trea …
- セバシン酸の世界市場2018-2022About Sebacic Acid Sebracic acid is a white powdered crystal that is resolved in ethanol and ether, and it possess low water solubility. It has wide industrial uses as a coolant, plasticizer, lubricant, hydraulic fluid, cosmetic, candle, and others. It is also used in the synthesis of polyamide and alkyd resins and as an intermediate for aromatics, antiseptics, and painting materials. Technavio’s …
- フラボノイドの世界市場分析：製品別（アントシアニン、フラボン、アンホキサンチン）、用途別（機能性飲料、機能性食品、栄養補助食品）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、CSA、MEA）、セグメント予測、2014-2025Theglobal flavonoids market is expected to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles and rising demand for beauty & health supplements are expected to propel flavonoids consumption over the forecast period. Developed countries such as Denmark, France, Australia, Belgium, Norway, and the U.S. are characterized by high cancer …
- スパンメル不織布の世界市場展望2017-20276According to Stratistics MRC, the Global Spunmelt Non-woven Fabrics Market is accounted for $22.30 billion in 2017 and is expected to reach $47.48 billion by 2026 growing at a CAGR of 8.7% during the forecast period. Some of the key factors influencing the market are growth of modern healthcare in developing markets, rise in the birth rate in emerging economies and increase in geriatric population …
- 皮革製品の世界市場：革製フットウェア、革製バッグ・財布、革製旅行用かばん、革製アクセサリーAbout Global Leather Goods MarketThe global leather goods market has been registering positive growth over the last few years and is shaping up to become one of the top competitive markets at a global level. With the rise in globalization, ample growth opportunities are being created in the market. Technavio’s analysts forecast the global leather goods market to grow at a CAGR of 4.37% during the …
- モノマー市場動向：April 2013Monomer World - April 2013 Summary Global monomer prices continued their declining trend in April 2013, after monomer supply continued to increase in most regions. With the exception of the European ethylene market, monomer supplies were plentiful in comparison with demand. Prices declined both in the first and second halves of April. Scope - Analyses monthly price trends in Asia, Europe and North …
- シリコーンの世界市場2020-2024Global Silicones Market 2020-2024 Technavio has been monitoring the silicones and it is poised to grow by USD 5.46 billion during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on silicones provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to- …
- フルフリルアミンの世界市場Ceramide (CAS 100403-19-8) Market Research Report 2013 presents comprehensive data on ceramide markets globally and regionally (Europe, Asia, North America etc.) The Ceramide (CAS 100403-19-8) Market Research Report 2013 includes ceramide description, covers its application areas and related patterns. It overviews ceramide market, names ceramide producers and indicates its suppliers. Besides, the …
- 世界の潤滑剤（Lubricant）市場動向（2014-2018）TechNavio's analysts forecast the Global Lubricant market to grow at a CAGR of 2.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand from the Automotive industry. The Global Lubricant market has also been witnessing the development of environment-friendly lubricants. However, the increasing negative impact on the environment coul …
- 世界の経肺薬物送達システム市場動向（2012-2016）TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. How …
- 全身性エリテマトーデス/ループス腎炎治療薬の世界市場予測および分析PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The lupus therapeutics market is dominated by generics and GlaxoSmithKline’s Benlysta is the only drug that has gained marketing approval for SLE in more than 50 years. Following Benlysta’s launch, patients’ uptake has remained low, but due to its associate …
- 異染性白質ジストロフィー(MLD)治療のグローバル臨床試験動向（2014年H2）Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014" provides data on the Metachromatic Leukodystrophy (MLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metachromatic Leukodystrophy (MLD). …
- 世界のインフルエンザ検査市場The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- 金属スタンピング加工の世界市場About Metal Stamping Metal stamping refers to a metal forming process in which a metal sheet is punched or pressed by a die to form the desired metal shape. Punching or pressing process can be carried out manually or can be automated depending on the requirement. Metals such as steel, stainless steel, brass, aluminum, and copper are used in the metal stamping process. Stamped components are widely …
- 2014年戦略提言：イギリスの臨床化学・免疫診断市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.“2014 Strategies for the UK Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the UK market; …
